<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737980</url>
  </required_header>
  <id_info>
    <org_study_id>JMC0023RSOP</org_study_id>
    <nct_id>NCT04737980</nct_id>
  </id_info>
  <brief_title>Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair</brief_title>
  <official_title>Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair: a Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a comparison of analgesia effect from peripheral nerve blockade (PNB) with&#xD;
      liposomal bupivacaine combined with bupivacaine compared to PNB with ropivacaine combined&#xD;
      with dexamethasone for arthroscopic rotator cuff repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthroscopic rotator cuff repair(ARCR) addresses dysfunction and pain in individuals with&#xD;
      rotator cuff tears who have failed conservative management. These procedures are typically&#xD;
      performed in an outpatient setting. Single shot PNB with long acting local anesthetics have&#xD;
      become the foundation of modern multimodal analgesia protocols. The reported analgesic&#xD;
      benefits of PNB for shoulder surgery include reduced pain scores, opioid consumption,&#xD;
      post-operative nausea and vomiting, improved postoperative recovery and improvement of&#xD;
      patient satisfaction. However, standard PNB with bupivacaine or ropivacaine have been&#xD;
      associated with rebound pain resulting in a sudden onset of pain that can be refractory to&#xD;
      treatment and often necessitates the use of significant quantities of opioids.&#xD;
&#xD;
      Side effects of opioid consumption include nausea, vomiting, sedation, constipation,&#xD;
      respiratory depression, hypotension, ileus, urinary retention, dehydration and addiction. It&#xD;
      is therefore desirable to minimize the requirement for opioid consumption after ARCR.&#xD;
&#xD;
      Liposomal bupivacaine injectable suspension and its potential use for PNB has been a recent&#xD;
      topic of interest in an effort to provide patients with longer acting pain control after&#xD;
      shoulder surgery compared to the use of bupivacaine or ropivacaine. Liposomal bupivacaine has&#xD;
      a delayed onset of action so its practical use for PNB for ARCR requires the additive of&#xD;
      bupivacaine to reduce pain during and immediately after surgery as a bridge to the onset of&#xD;
      liposomal bupivacaine.&#xD;
&#xD;
      The purpose of this study is to determine if PNB utilizing liposomal bupivacaine combined&#xD;
      with bupivacaine performs favorably to standard PNB with ropivacaine combined with&#xD;
      dexamethasone. Primary and secondary outcomes will be assessed including worst pain reported&#xD;
      postoperatively on a numeric rating scale(NRS), postoperative opioid consumption reported as&#xD;
      oral morphine equivalent dosage(OMED) and the overall benefit of anesthesia (OBAS) as&#xD;
      reported by the OBAS score.&#xD;
&#xD;
      The hypothesis of this study is that PNB with liposomal bupivacaine combined with bupivacaine&#xD;
      will translate to lower postoperative daily NRS pain scores, decreased daily and total OMED&#xD;
      consumed and lower OBAS scores compared to PNB with ropivacaine combined with dexamethasone&#xD;
      over the first 8 days following surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 18, 2019</start_date>
  <completion_date type="Actual">March 18, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study utilized two parallel arms for intervention. Participants were randomized to ultrasound guided PNB with liposomal bupivacaine combined with bupivacaine or PNB with ropivacaine combined with dexamethasone.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The participant was informed of which arm they were in after random draw as this information may have been important in the event they experienced side effects and needed to guide physician care at outside facilities. The anesthesiologist could not be masked regarding arm as the appearance of the medicine injected in both arms of the study was visibly different. The outcome assessor was masked by unique identifiers being applied to participants and outcome data kept separate from intervention arm until final analysis.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Daily morphine milligram equivalents of opioid</measure>
    <time_frame>up to 8 days</time_frame>
    <description>Daily opioid consumption reported as OMED</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total opioid consumption in morphine milligram equivalents</measure>
    <time_frame>8 day period</time_frame>
    <description>Total opioid consumption for entire 8 days after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant reported &quot;worst pain&quot; level on a numeric rating scale after surgery</measure>
    <time_frame>up to 8 days</time_frame>
    <description>Worst pain level experienced as reported on a numeric rating scale by a participant for each preceding 24 hour period. 0 on numeric rating scale denoting no pain and 10 denoting worst possible pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall benefit of anesthesia score (OBAS)</measure>
    <time_frame>up to 8 days</time_frame>
    <description>Overall benefit of anesthesia score (OBAS) as reported by a participant for each preceding 24 hour period. OBAS is a numeric rating scale. A lower value denotes better pain control and less side effects from anesthesia. Range of scores from 0 to 28.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in pain from baseline</measure>
    <time_frame>up to 8 days</time_frame>
    <description>Participant reported change in &quot;worst pain&quot; level on numeric rating scale from baseline (preoperative) &quot;worst pain&quot; to &quot;worst pain&quot; reported on each day after surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Rotator Cuff Tears</condition>
  <condition>Shoulder Pain</condition>
  <arm_group>
    <arm_group_label>Experimental Group: Interscalene block with liposomal bupivacaine combined with bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interscalene nerve block was performed utilizing ultrasound guidance with infiltration of 10 ml of liposomal bupivacaine 1.3% (133 mg) combined with 10 ml of 0.5% bupivacaine hydrochloride.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group: Interscalene block with ropivacaine combined with dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interscalene nerve block was performed utilizing ultrasound guidance with infiltration of 30ml of 0.5% ropivacaine combined with a 2 ml volume of 8mg of dexamethasone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal bupivacaine</intervention_name>
    <description>Injection of 10 ml of liposomal bupivacaine 1.3% (133 mg) for ultrasound guided interscalene block</description>
    <arm_group_label>Experimental Group: Interscalene block with liposomal bupivacaine combined with bupivacaine</arm_group_label>
    <other_name>Exparel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hcl 0.5% Inj</intervention_name>
    <description>Injection of 10 ml of 0.5% bupivacaine hydrochloride as admixture for ultrasound guided interscalene block</description>
    <arm_group_label>Experimental Group: Interscalene block with liposomal bupivacaine combined with bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% Injectable Solution</intervention_name>
    <description>Injection of 30 ml of ropivacaine 0.5% injectable solution for ultrasound guided interscalene block</description>
    <arm_group_label>Control Group: Interscalene block with ropivacaine combined with dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Injection of 8mg (2ml) dexamethasone injectable as admixture</description>
    <arm_group_label>Control Group: Interscalene block with ropivacaine combined with dexamethasone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Full thickness tears of the Supraspinatus tendon&#xD;
&#xD;
          -  Combined full thickness tears of the Supraspinatus and Infraspinatus tendon&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18&#xD;
&#xD;
          -  Revision surgery&#xD;
&#xD;
          -  Chronic opioid use (&gt;3 months prior to surgery)&#xD;
&#xD;
          -  Allergy to local anesthetics or opioids&#xD;
&#xD;
          -  Workers compensation or medical legal claim&#xD;
&#xD;
          -  Pulmonary disease&#xD;
&#xD;
          -  NSAID intolerance&#xD;
&#xD;
          -  Neurologic deficit of operative upper extremity&#xD;
&#xD;
          -  Concomitant full thickness subscapularis tear&#xD;
&#xD;
               -  2 tendon rotator cuff tear&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>HSS Florida</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Uquillas CA, Capogna BM, Rossy WH, Mahure SA, Rokito AS. Postoperative pain control after arthroscopic rotator cuff repair. J Shoulder Elbow Surg. 2016 Jul;25(7):1204-13. doi: 10.1016/j.jse.2016.01.026. Epub 2016 Apr 11. Review.</citation>
    <PMID>27079219</PMID>
  </results_reference>
  <results_reference>
    <citation>Hussain N, Brull R, Sheehy B, Essandoh MK, Stahl DL, Weaver TE, Abdallah FW. Perineural Liposomal Bupivacaine Is Not Superior to Nonliposomal Bupivacaine for Peripheral Nerve Block Analgesia. Anesthesiology. 2021 Feb 1;134(2):147-164. doi: 10.1097/ALN.0000000000003651.</citation>
    <PMID>33372953</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdallah FW, Halpern SH, Aoyama K, Brull R. Will the Real Benefits of Single-Shot Interscalene Block Please Stand Up? A Systematic Review and Meta-Analysis. Anesth Analg. 2015 May;120(5):1114-1129. doi: 10.1213/ANE.0000000000000688. Review.</citation>
    <PMID>25822923</PMID>
  </results_reference>
  <results_reference>
    <citation>Namdari S, Nicholson T, Abboud J, Lazarus M, Steinberg D, Williams G. Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty: A Randomized Controlled Trial. J Bone Joint Surg Am. 2018 Aug 15;100(16):1373-1378. doi: 10.2106/JBJS.17.01416.</citation>
    <PMID>30106818</PMID>
  </results_reference>
  <results_reference>
    <citation>Namdari S, Nicholson T, Abboud J, Lazarus M, Steinberg D, Williams G. Randomized Controlled Trial of Interscalene Block Compared with Injectable Liposomal Bupivacaine in Shoulder Arthroplasty. J Bone Joint Surg Am. 2017 Apr 5;99(7):550-556. doi: 10.2106/JBJS.16.00296.</citation>
    <PMID>28375887</PMID>
  </results_reference>
  <results_reference>
    <citation>Kolade O, Patel K, Ihejirika R, Press D, Friedlander S, Roberts T, Rokito AS, Virk MS. Efficacy of liposomal bupivacaine in shoulder surgery: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2019 Sep;28(9):1824-1834. doi: 10.1016/j.jse.2019.04.054. Epub 2019 Jul 16.</citation>
    <PMID>31324503</PMID>
  </results_reference>
  <results_reference>
    <citation>Yan Z, Chen Z, Ma C. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: A meta-analysis. Medicine (Baltimore). 2017 Jul;96(27):e7226. doi: 10.1097/MD.0000000000007226. Review.</citation>
    <PMID>28682872</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel MA, Gadsden JC, Nedeljkovic SS, Bao X, Zeballos JL, Yu V, Ayad SS, Bendtsen TF. Brachial Plexus Block with Liposomal Bupivacaine for Shoulder Surgery Improves Analgesia and Reduces Opioid Consumption: Results from a Multicenter, Randomized, Double-Blind, Controlled Trial. Pain Med. 2020 Feb 1;21(2):387-400. doi: 10.1093/pm/pnz103.</citation>
    <PMID>31150095</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang K, Zhang HX. Liposomal bupivacaine versus interscalene nerve block for pain control after total shoulder arthroplasty: A systematic review and meta-analysis. Int J Surg. 2017 Oct;46:61-70. doi: 10.1016/j.ijsu.2017.08.569. Epub 2017 Aug 24. Review.</citation>
    <PMID>28843463</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 23, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital for Special Surgery Florida</investigator_affiliation>
    <investigator_full_name>ryan simovitch</investigator_full_name>
    <investigator_title>Director-Shoulder Service</investigator_title>
  </responsible_party>
  <keyword>peripheral nerve block</keyword>
  <keyword>interscalene nerve block</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>liposomal bupivacaine</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

